This webinar features Katie Gudiksen, Senior Health Policy Researcher at UC Hastings. Gudiksen will discuss state laws addressing pharmacy prices and the utilization of these laws in driving higher-value in health care.
This webinar highlights new forms of life in the health care industry and the implications of these unconventional mergers for health care purchasers and other stakeholders. This webinar features Leemore Dafny of Harvard Business School and Bob Galvin, CEO of Equity Health Care.
This webinar features David Muhlestein, Chief Research Officer at Leavitt Partners, and Niall Brennan, President and CEO of the Health Care Cost Institute, on pricing pressure in health care and efforts to control costs through policy solutions.
This webinar focuses on efforts to modernize the physician fee schedule to drive higher-value in health care. This webinar features Mai Pham, MD, vice president of provider alignment solutions at Anthem Inc. and Bob Berenson, MD, institute fellow at the Urban Institute.
Webinar #1: The Case for Multifacted State Policy Intervention NEWSFLASH: HEALTH CARE MARKETS ARE BROKEN Everyone is tired of hearing about how broken our health care system is. We know:
Media Advisory: Catalyst for Payment Reform Releases State-based Policy Resources to Help Rein in Health Care Prices BERKELEY, CA – February 14, 2023 – As employers and other commercial health care
This webinar, the final in the series of four, focuses on policies, which, if plotted on a spectrum of “degree of intervention” would land on the lower end of the scale. It also offers strategies for states to protect the erosion of market competition by bolstering and broadening antitrust oversight. Featuring Josephine Porter, Director of the Institute for Health Policy and Practice at the University of New Hampshire and Jaime S. King, the John and Marylyn Mayo Chair in Health Law at the University of Auckland.
This webinar, third in a series of four, focuses on policies for price regulation, organized according to the degree of state oversight, resources and sophistication required to administer them. Featuring Anna Doar Sinaiko, Assistant Professor of Health Economics and Policy at Harvard University, Robert A. Berenson, an Institute Fellow at the Urban Institute’s Health Policy Center, and Robert Murray, President of Global Health Payment, LLC.
Market-based interventions have provided insufficient relief from rising commercial health care costs. As a result, states have a unique and pressing opportunity to enact policies that place downward pressure on unit prices and rebalance market power toward health care purchasers and consumers. The geographic, political, and economic diversity across the 50 United States opens possibilities for state governments to shape their own policy agendas; however, states will likely find that a single piece of legislation proves insufficient to deliver meaningful relief, and/or will create vulnerabilities that are easily exploited by stakeholders who benefit from the status quo. Therefore, state legislators may want to consider combinations or menus of policy options to create complementary infrastructure, close loopholes and plan for contingencies.
This webinar, the final in the series of four, focuses on policies, which, if plotted on a spectrum of “degree of intervention” would land on the lower end of the scale. It also offers strategies for states to protect the erosion of market competition by bolstering and broadening antitrust oversight. Featuring Josephine Porter, Director of the Institute for Health Policy and Practice at the University of New Hampshire and Jaime S. King, the John and Marylyn Mayo Chair in Health Law at the University of Auckland.
This webinar, third in a series of four, focuses on policies for price regulation, organized according to the degree of state oversight, resources and sophistication required to administer them. Featuring Anna Doar Sinaiko, Assistant Professor of Health Economics and Policy at Harvard University, Robert A. Berenson, an Institute Fellow at the Urban Institute’s Health Policy Center, and Robert Murray, President of Global Health Payment, LLC.
This webinar, second in a series of four, focuses on policies to prevent would-be monopolists from engaging in anticompetitive behavior, impose penalties on those that continue to do so, and protect and preserve the independent actors that remain. Featuring Aditi P. Sen, Director of Research and Policy at the Health Care Cost Institute and Erin Fuse Brown, the Catherine C. Henson Professor of Law and Director of the Center for Law, Health, and Society at Georgia State University.
Let’s face it. Something has got to give. While employers and health care purchasers have long tried to implement market-based solutions, catalyzing consistent and long lasting system-wide change in health
Back in 2016, benefits staff at CHG Healthcare found a charge for $174K in the monthly claims spend report. It wasn’t a mistake; it was the actual price for a specialty drug being used to treat a rare medical condition. Forecasting further exorbitant costs without evidence of effectiveness, CHG Healthcare partnered with VIVIO Health Inc in 2017 to implement a specialty drug carve-out plan that covers both pharmacy and medical benefit drugs. Between 2017 and 2020, the program netted this progressive purchaser $4.4M in savings with their plan participants paying $0 for their speciality medications.
Suzanne Delbanco Executive Director Speaker; Leading Expert in Payment Reform, Focusing on Intersection of Higher-Value Health Care and Price Transparency; Nine-time Selectee of Modern Healthcare’s 100 Most Influential People in
Market-based interventions have provided insufficient relief from rising commercial health care costs. As a result, states have a unique and pressing opportunity to enact policies that place downward pressure on unit prices and rebalance market power toward health care purchasers and consumers. The geographic, political, and economic diversity across the 50 United States opens possibilities for state governments to shape their own policy agendas; however, states will likely find that a single piece of legislation proves insufficient to deliver meaningful relief, and/or will create vulnerabilities that are easily exploited by stakeholders who benefit from the status quo. Therefore, state legislators may want to consider combinations or menus of policy options to create complementary infrastructure, close loopholes and plan for contingencies.
Market-based interventions have provided insufficient relief from rising commercial health care costs. As a result, states have a unique and pressing opportunity to enact policies that place downward pressure on unit prices and rebalance market power toward health care purchasers and consumers. The geographic, political, and economic diversity across the 50 United States opens possibilities for state governments to shape their own policy agendas; however, states will likely find that a single piece of legislation proves insufficient to deliver meaningful relief, and/or will create vulnerabilities that are easily exploited by stakeholders who benefit from the status quo. Therefore, state legislators may want to consider combinations or menus of policy options to create complementary infrastructure, close loopholes and plan for contingencies.
Market-based interventions have provided insufficient relief from rising commercial health care costs. As a result, states have a unique and pressing opportunity to enact policies that place downward pressure on unit prices and rebalance market power toward health care purchasers and consumers. The geographic, political, and economic diversity across the 50 United States opens possibilities for state governments to shape their own policy agendas; however, states will likely find that a single piece of legislation proves insufficient to deliver meaningful relief, and/or will create vulnerabilities that are easily exploited by stakeholders who benefit from the status quo. Therefore, state legislators may want to consider combinations or menus of policy options to create complementary infrastructure, close loopholes and plan for contingencies.
Market-based interventions have provided insufficient relief from rising commercial health care costs. As a result, states have a unique and pressing opportunity to enact policies that place downward pressure on unit prices and rebalance market power toward health care purchasers and consumers. The geographic, political, and economic diversity across the 50 United States opens possibilities for state governments to shape their own policy agendas; however, states will likely find that a single piece of legislation proves insufficient to deliver meaningful relief, and/or will create vulnerabilities that are easily exploited by stakeholders who benefit from the status quo. Therefore, state legislators may want to consider combinations or menus of policy options to create complementary infrastructure, close loopholes and plan for contingencies.
Market-based interventions have provided insufficient relief from rising commercial health care costs. As a result, states have a unique and pressing opportunity to enact policies that place downward pressure on unit prices and rebalance market power toward health care purchasers and consumers. The geographic, political, and economic diversity across the 50 United States opens possibilities for state governments to shape their own policy agendas; however, states will likely find that a single piece of legislation proves insufficient to deliver meaningful relief, and/or will create vulnerabilities that are easily exploited by stakeholders who benefit from the status quo. Therefore, state legislators may want to consider combinations or menus of policy options to create complementary infrastructure, close loopholes and plan for contingencies.
Our webinars are supported by the Peterson Center on Healthcare as part of an initiative to help employers be more effective purchasers of healthcare.
